Number of shares and voting rights of Innate Pharma as of February 1, 2021
Innate Pharma to participate in the 10th annual SVB Leerink Global Healthcare Conference
Innate Pharma advances lacutamab clinical development program
Innate Pharma to host key opinion leader discussion on the potential role of lacutamab across T-cell lymphomas
Innate's first NK cell engager selected by Sanofi as drug candidate for development
Innate Pharma to participate in upcoming investor conferences
Innate Pharma to return US and EU Lumoxiti commercialization rights to AstraZeneca
Innate Pharma to present additional efficacy data for monalizumab in combination with cetuximab in head and neck cancer at the ESMO immuno-oncology virtual congress
Innate Pharma 2021 financial calendar
Innate Pharma reports third quarter 2020 financial results and business update
